FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Tomokazu Yoshizaki

Research Profile

Disorders

Chemicals & Drugs

Living Beings

Human Herpesvirus 4

Procedures

Immunohistochemistry

Anatomy

Physiology

Transfection

Co-author Network

Publications

TOP 3
Noriko Kitagawa; Satoru Kondo; Shigeyuki Murono; Yosuke Nakanishi; Akira Tsuji; Naohiro Wakisaka; Kazuhira Endo; Yoh Zen; Tomokazu Yoshizaki
Expression of seven-in-absentia homologue 1 and hypoxia-inducible factor 1 alpha: novel prognostic factors of nasopharyngeal carcinoma.
Shigeyuki Murono; Y Nakanishi; M Fujimoto; Tomokazu Yoshizaki
Hypopharyngeal presentation of cicatricial pemphigoid: videofluorographic and direct laryngoscopic findings.
Kazuhira Endo; Julia Shackelford; Tomokazu Yoshizaki; Mitsuharu Aga; Joseph S Pagano
Upregulation of special AT-rich-binding protein 1 by Epstein-Barr virus latent membrane protein 1 in human nasopharyngeal cells and nasopharyngeal cancer.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Tomokazu Yoshizaki (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Noriko Kitagawa; Satoru Kondo; Shigeyuki Murono; Yosuke Nakanishi; Akira Tsuji; Naohiro Wakisaka; Kazuhira Endo; Yoh Zen; Tomokazu Yoshizaki
Expression of seven-in-absentia homologue 1 and hypoxia-inducible factor 1 alpha: novel prognostic factors of nasopharyngeal carcinoma.
Cancer letters 2013;331(1):52-7.
2013: Shigeyuki Murono; Y Nakanishi; M Fujimoto; Tomokazu Yoshizaki
Hypopharyngeal presentation of cicatricial pemphigoid: videofluorographic and direct laryngoscopic findings.
The Journal of laryngology and otology 2013;127(4):429-31.
2013: Kazuhira Endo; Julia Shackelford; Tomokazu Yoshizaki; Mitsuharu Aga; Joseph S Pagano
Upregulation of special AT-rich-binding protein 1 by Epstein-Barr virus latent membrane protein 1 in human nasopharyngeal cells and nasopharyngeal cancer.
The Journal of general virology 2013;94(Pt 3):507-13.
2013: Kazuhira Endo; Makoto Ito; Kazunori Kataoka; Yasuki Kato; Satoru Kondo; Shigeyuki Murono; Takayoshi Ueno; Naohiro Wakisaka; Tomokazu Yoshizaki
Tumor-targeted chemotherapy with the nanopolymer-based drug NC-6004 for oral squamous cell carcinoma.
Cancer science 2013;104(3):369-74.
2013: Shigeyuki Murono; Naohiro Wakisaka; Kazuhira Endo; Satoru Kondo; Tomokazu Yoshizaki
Oncological and functional outcome after transoral 532-nm pulsed potassium-titanyl-phosphate laser surgery for T1a glottic carcinoma.
Lasers in medical science 2013;28(2):615-9.
2013: Yosuke Nakanishi; Akira Tsuji; Naohiro Wakisaka; Kazuhira Endo; Makoto Ito; Kouichi Kitamura; Satoru Kondo; Masamichi Muramatsu; Shigeyuki Murono; Tomokazu Yoshizaki
Role of activation-induced cytidine deaminase in the development of oral squamous cell carcinoma.
PloS one 2013;8(4):e62066.
2012: Kyoko Hirota; Satoru Kondo; Shigeyuki Murono; Seiko Sawada-Kitamura; Akira Tsuji; Naohiro Wakisaka; Kazuhira Endo; Tomokazu Yoshizaki
Lymphangiogenesis in regional lymph nodes predicts nodal recurrence in pathological N0 squamous cell carcinoma of the tongue.
Histopathology 2012;61(6):1065-71.
2012: Hisashi Sugimoto; Miyako Hatano; Makoto Ito; Tomokazu Yoshizaki
Cochlear implantation in a patient with superficial siderosis.
Auris, nasus, larynx 2012;39(6):623-6.
2012: Makoto Ito; Satoru Kondo; Yumiko Maruyama; Takaki Miwa; Shigeyuki Murono; Sayaka Nakanishi; Naohiro Wakisaka; Miyako Hatano; Tomokazu Yoshizaki
Efficacy and safety of garenoxacin in the treatment of upper respiratory tract infections.
Auris, nasus, larynx 2012;39(5):512-8.
2012: Naohiro Wakisaka; Kazuhira Endo; Satoru Kondo; Shigeyuki Murono; Tomokazu Yoshizaki
Adjuvant chemotherapy with an oral fluoropyrimidine, S-1, following reduced RADPLAT in advanced laryngeal cancer.
The Annals of otology, rhinology, and laryngology 2012;121(8):555-62.
2012: Miyako Hatano; Makoto Ito; Tomokazu Yoshizaki; Jack B Kelly
Changes in projections to the inferior colliculus following early hearing loss in rats.
Hearing research 2012;287(1-2):57-66.
2012: Tomokazu Yoshizaki; Makoto Ito; Satoru Kondo; Shigeyuki Murono; Naohiro Wakisaka; Kazuhira Endo
Current understanding and management of nasopharyngeal carcinoma.
Auris, nasus, larynx 2012;39(2):137-44.
2011: Satoru Kondo; Masamichi Muramatsu; Shigeyuki Murono; Joseph S Pagano; Hisashi Sugimoto; Naohiro Wakisaka; Shoji Yamaoka; Kazuhira Endo; Yoh Zen; Tomokazu Yoshizaki
Epstein-Barr virus latent membrane protein 1 induces cancer stem/progenitor-like cells in nasopharyngeal epithelial cell lines.
Journal of virology 2011;85(21):11255-64.
2011: Hisashi Sugimoto; Shinya Yoshida; Miyako Hatano; Makoto Ito; Tomokazu Yoshizaki
Concurrent superselective intra-arterial chemotherapy and radiotherapy for late-stage squamous cell carcinoma of the temporal bone.
The Annals of otology, rhinology, and laryngology 2011;120(6):372-6.
2011: T Horikawa; Tomokazu Yoshizaki; S Kondo; Mitsuru Furukawa; Yasuharu Kaizaki; Joseph S Pagano
Epstein-Barr Virus latent membrane protein 1 induces Snail and epithelial-mesenchymal transition in metastatic nasopharyngeal carcinoma.
British journal of cancer 2011;104(7):1160-7.
2011: Tomokazu Yoshizaki
A novel immune evasion mechanism of LMP-1, an EBV-primary oncogene, in nasopharyngeal carcinoma.
Advances in oto-rhino-laryngology 2011;72():157-9.
2010: Makoto Ito; Muneki Hotomi; Yumiko Maruyama; Miyako Hatano; Hisashi Sugimoto; Tomokazu Yoshizaki; Noboru Yamanaka
Clonal spread of beta-lactamase-producing amoxicillin-clavulanate-resistant (BLPACR) strains of non-typeable Haemophilus influenzae among young children attending a day care in Japan.
International journal of pediatric otorhinolaryngology 2010;74(8):901-6.
2009: Shigeyuki Murono; Kyoko Hirota; Satoru Kondo; Naohiro Wakisaka; Mitsuru Furukawa; Tomokazu Yoshizaki
An extremely rare case of large Delphian node metastasis preceding primary laryngeal cancer.
Auris, nasus, larynx 2009;36(5):614-7.
2009: Naohiro Wakisaka; Satoru Kondo; Shigeyuki Murono; Hiroshi Minato; Mitsuru Furukawa; Tomokazu Yoshizaki
A solitary fibrous tumor arising in the parapharyngeal space, with MRI and FDG-PET findings.
Auris, nasus, larynx 2009;36(3):367-71.
2009: K Endo; S Kondo; J Shackleford; Toshiyuki Horikawa; N Kitagawa; Tomokazu Yoshizaki; M Furukawa; Y Zen; Joseph S Pagano
Phosphorylated ezrin is associated with EBV latent membrane protein 1 in nasopharyngeal carcinoma and induces cell migration.
Oncogene 2009;28(14):1725-35.
2009: Tomokazu Yoshizaki; Satoru Kondo; Naohiro Wakisaka; Shigeyuki Murono; Noriko Kitagawa; Akira Tsuji; Masashi Nakashima; Junichiro Sanada; Osamu Matsui
Concurrent intra-arterial chemotherapy and radiotherapy for advanced laryngeal cancer.
The Annals of otology, rhinology, and laryngology 2009;118(3):172-8.
2009: Naoki Uramoto; Mitsuru Furukawa; Tomokazu Yoshizaki
Malignant phosphaturic mesenchymal tumor, mixed connective tissue variant of the tongue.
Auris, nasus, larynx 2009;36(1):104-5.
2008: Akira Tsuji; Naohiro Wakisaka; Satoru Kondo; Shigeyuki Murono; Mitsuru Furukawa; Tomokazu Yoshizaki
Induction of receptor for advanced glycation end products by EBV latent membrane protein 1 and its correlation with angiogenesis and cervical lymph node metastasis in nasopharyngeal carcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(17):5368-75.
2008: Yoshinori Shimizu; Satoru Kondo; Akiko Shirai; Mitsuru Furukawa; Tomokazu Yoshizaki
A single nucleotide polymorphism in the matrix metalloproteinase-1 and interleukin-8 gene promoter predicts poor prognosis in tongue cancer.
Auris, nasus, larynx 2008;35(3):381-9.
2008: Tomokazu Yoshizaki
[Limitations in intra-arterial infusions of chemotherapy for head and neck cancer].
Gan to kagaku ryoho. Cancer & chemotherapy 2008;35(7):1106-9.
2008: Masashi Nakashima; Satoru Kondo; Yoshinori Shimizu; Naohiro Wakisaka; Shigeyuki Murono; Mitsuru Furukawa; Tomokazu Yoshizaki
Impact of MDM2 single nucleotide polymorphism on tumor onset in head and neck squamous cell carcinoma.
Acta oto-laryngologica 2008;128(7):808-13.
2008: Naohiro Wakisaka; Shigeyuki Murono; Satoru Kondo; Mitsuru Furukawa; Tomokazu Yoshizaki
Post-operative pharyngocutaneous fistula after laryngectomy.
Auris, nasus, larynx 2008;35(2):203-8.
2008: Tomokazu Yoshizaki; Naohiro Wakisaka; Satoru Kondo; Shigeyuki Murono; Yoshinori Shimizu; Masashi Nakashima; Akira Tsuji; Mitsuru Furukawa
Treatment of locally recurrent Epstein-Barr virus-associated nasopharyngeal carcinoma using the anti-viral agent cidofovir.
Journal of medical virology 2008;80(5):879-82.
2007: Tomokazu Yoshizaki; Naohiro Wakisaka; Shigeyuki Murono; Satoru Kondo; Yoshinori Shimizu; Tsuyoshi Takanaka; Junichiro Sanada; Noboru Terayama; Osamu Matsui; Mitsuru Furukawa
Intra-arterial chemotherapy less intensive than RADPLAT with concurrent radiotherapy for resectable advanced head and neck squamous cell carcinoma: a prospective study.
The Annals of otology, rhinology, and laryngology 2007;116(10):754-61.
2007: Toshiyuki Horikawa; Jing Yang; Satoru Kondo; Tomokazu Yoshizaki; Irene Joab; Mitsuru Furukawa; Joseph S Pagano
Twist and epithelial-mesenchymal transition are induced by the EBV oncoprotein latent membrane protein 1 and are associated with metastatic nasopharyngeal carcinoma.
Cancer research 2007;67(5):1970-8.
2007: Tomokazu Yoshizaki; Kazuhira Endo; Qingchun Ren; Naohiro Wakisaka; Shigeyuki Murono; Satoru Kondo; Hiroshi Sato; Mitsuru Furukawa
Oncogenic role of Epstein-Barr virus-encoded small RNAs (EBERs) in nasopharyngeal carcinoma.
Auris, nasus, larynx 2007;34(1):73-8.
2007: Satoru Kondo; Tomokazu Yoshizaki; Naohiro Wakisaka; Toshiyuki Horikawa; Shigeyuki Murono; Kyung Lib Jang; Irene Joab; Mitsuru Furukawa; Joseph S Pagano
MUC1 induced by Epstein-Barr virus latent membrane protein 1 causes dissociation of the cell-matrix interaction and cellular invasiveness via STAT signaling.
Journal of virology 2007;81(4):1554-62.
2006: Naohiro Wakisaka; Shigeyuki Murono; Hiroshi Minato; Mitsuru Furukawa; Tomokazu Yoshizaki
A case report: Epstein-Barr virus-associated undifferentiated carcinoma of the tongue base.
Auris, nasus, larynx 2006;33(4):487-91.
2006: Satoru Kondo; So Young Seo; Tomokazu Yoshizaki; Naohiro Wakisaka; Mitsuru Furukawa; Irene Joab; Kyung Lib Jang; Joseph S Pagano
EBV latent membrane protein 1 up-regulates hypoxia-inducible factor 1alpha through Siah1-mediated down-regulation of prolyl hydroxylases 1 and 3 in nasopharyngeal epithelial cells.
Cancer research 2006;66(20):9870-7.
2006: Naohiro Wakisaka; Takaki Miwa; Tomokazu Yoshizaki; Mitsuru Furukawa
Cricoid ossification mimicking an impacted foreign body.
The Journal of laryngology and otology 2006;120(7):E24.
2006: Noboru Terayama; Junichiro Sanada; Osamu Matsui; Satoshi Kobayashi; Hiroko Kawashima; Masashi Yamashiro; Tsuyoshi Takanaka; Tomoyasu Kumano; Tomokazu Yoshizaki; Mitsuru Furukawa
Feeding artery of laryngeal and hypopharyngeal cancers: role of the superior thyroid artery in superselective intraarterial chemotherapy.
Cardiovascular and interventional radiology 2006;29(4):536-43.
2006: Munirah Ahmad; Takahisa Takino; Hisashi Miyamori; Tomokazu Yoshizaki; Mitsuru Furukawa; Hiroshi Sato
Cleavage of amyloid-beta precursor protein (APP) by membrane-type matrix metalloproteinases.
Journal of biochemistry 2006;139(3):517-26.
2005: Naohiro Wakisaka; Tomokazu Yoshizaki; Nancy Raab-Traub; Joseph S Pagano
Ribonucleotide reductase inhibitors enhance cidofovir-induced apoptosis in EBV-positive nasopharyngeal carcinoma xenografts.
International journal of cancer. Journal international du cancer 2005;116(4):640-5.
2005: Tomokazu Yoshizaki; Naohiro Wakisaka; Shigeyuki Murono; Yoshinori Shimizu; Mitsuru Furukawa
Endoscopic nasopharyngectomy for patients with recurrent nasopharyngeal carcinoma at the primary site.
The Laryngoscope 2005;115(8):1517-9.
2005: Satoru Kondo; Naohiro Wakisaka; Michael J Schell; Toshiyuki Horikawa; Tzung-Shiahn Sheen; Hiroshi Sato; Mitsuru Furukawa; Joseph S Pagano; Tomokazu Yoshizaki
Epstein-Barr virus latent membrane protein 1 induces the matrix metalloproteinase-1 promoter via an Ets binding site formed by a single nucleotide polymorphism: enhanced susceptibility to nasopharyngeal carcinoma.
International journal of cancer. Journal international du cancer 2005;115(3):368-76.
2004: Tomokazu Yoshizaki; Hidenori Kinsen; Hiroshi Minato; Toshiyuki Kita; Mitsuru Furukawa
Metastasizing mixed tumour of the parotid gland presenting as multiple lung metastases.
The Journal of laryngology and otology 2004;118(9):724-6.
2004: Satoru Kondo; Toshiyuki Horikawa; Hajime Takeshita; Chiharu Kanegane; Yoshihito Kasahara; Tzung-Shiahn Sheen; Hiroshi Sato; Mitsuru Furukawa; Tomokazu Yoshizaki
Diagnostic value of serum EBV-DNA quantification and antibody to viral capsid antigen in nasopharyngeal carcinoma patients.
Cancer science 2004;95(6):508-13.
2004: Naohiro Wakisaka; Satoru Kondo; Tomokazu Yoshizaki; Shigeyuki Murono; Mitsuru Furukawa; Joseph S Pagano
Epstein-Barr virus latent membrane protein 1 induces synthesis of hypoxia-inducible factor 1 alpha.
Molecular and cellular biology 2004;24(12):5223-34.
2004: Qingchun Ren; Hiroshi Sato; Shigeyuki Murono; Mitsuru Furukawa; Tomokazu Yoshizaki
Epstein-Barr virus (EBV) latent membrane protein 1 induces interleukin-8 through the nuclear factor-kappa B signaling pathway in EBV-infected nasopharyngeal carcinoma cell line.
The Laryngoscope 2004;114(5):855-9.
2003: Akiko Shirai; Mitsuru Furukawa; Tomokazu Yoshizaki
Expression of intercellular adhesion molecule (ICAM)-1 in adenoid cystic carcinoma of the head and neck.
The Laryngoscope 2003;113(11):1955-60.
2003: Kazuhira Endo; Takahisa Takino; Hisashi Miyamori; Hidenori Kinsen; Tomokazu Yoshizaki; Mitsuru Furukawa; Hiroshi Sato
Cleavage of syndecan-1 by membrane type matrix metalloproteinase-1 stimulates cell migration.
The Journal of biological chemistry 2003;278(42):40764-70.
2003: Hidenori Kinsenn; Hiroshi Sato; Mitsuru Furukawa; Tomokazu Yoshizaki
Modulation of cell growth and matrix metalloproteinase-2 activation of oral squamous cell carcinoma as a function of culture condition with type I collagen.
Acta oto-laryngologica 2003;123(8):987-93.
2002: Naohiro Wakisaka; Shigeyuki Murono; Tomokazu Yoshizaki; Mitsuru Furukawa; Joseph S Pagano
Epstein-barr virus latent membrane protein 1 induces and causes release of fibroblast growth factor-2.
Cancer research 2002;62(21):6337-44.
2002: Ken-ichi Maekawa; Hiroshi Sato; Mitsuru Furukawa; Tomokazu Yoshizaki
Inhibition of cervical lymph node metastasis by marimastat (BB-2516) in an orthotopic oral squamous cell carcinoma implantation model.
Clinical & experimental metastasis 2002;19(6):513-8.
2002: Tomokazu Yoshizaki
Promotion of metastasis in nasopharyngeal carcinoma by Epstein-Barr virus latent membrane protein-1.
Histology and histopathology 2002;17(3):845-50.
2002: Tomokazu Yoshizaki; Yuji Himi; Hiroshi Minato; Ikuko Ogawa; Hiromasa Nikai; Mitsuru Furukawa
Malignant myoepithelioma arising from recurrent pleomorphic adenoma of minor salivary gland.
Auris, nasus, larynx 2002;29(1):91-4.
2001: Tomokazu Yoshizaki; Toshiyuki Horikawa; R Qing-Chun; Naohiro Wakisaka; H Takeshita; Tzung-Shiahn Sheen; S Y Lee; Hiroshi Sato; Mitsuru Furukawa
Induction of interleukin-8 by Epstein-Barr virus latent membrane protein-1 and its correlation to angiogenesis in nasopharyngeal carcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2001;7(7):1946-51.
2001: Toshiyuki Horikawa; Tzung-Shiahn Sheen; H Takeshita; Hiroshi Sato; Mitsuru Furukawa; Tomokazu Yoshizaki
Induction of c-Met proto-oncogene by Epstein-Barr virus latent membrane protein-1 and the correlation with cervical lymph node metastasis of nasopharyngeal carcinoma.
The American journal of pathology 2001;159(1):27-33.
2001: Shigeyuki Murono; H Inoue; T Tanabe; Irene Joab; Tomokazu Yoshizaki; Manabu Furukawa; Joseph S Pagano
Induction of cyclooxygenase-2 by Epstein-Barr virus latent membrane protein 1 is involved in vascular endothelial growth factor production in nasopharyngeal carcinoma cells.
Proceedings of the National Academy of Sciences of the United States of America 2001;98(12):6905-10.
2001: Tomokazu Yoshizaki; Y Maruyama; Hiroshi Sato; Mitsuru Furukawa
Expression of tissue inhibitor of matrix metalloproteinase-2 correlates with activation of matrix metalloproteinase-2 and predicts poor prognosis in tongue squamous cell carcinoma.
International journal of cancer. Journal international du cancer 2001;95(1):44-50.
2000: A Tatsumi-Tamori; Tomokazu Yoshizaki; Takaki Miwa; Mitsuru Furukawa
Clinical evaluation of staging system for nasopharyngeal carcinoma: comparison of fourth and fifth editions of UICC TNM classification.
The Annals of otology, rhinology, and laryngology 2000;109(12 Pt 1):1125-9.
2000: T Horikawa; Tomokazu Yoshizaki; Tzung-Shiahn Sheen; S Y Lee; M Furukawa
Association of latent membrane protein 1 and matrix metalloproteinase 9 with metastasis in nasopharyngeal carcinoma.
Cancer 2000;89(4):715-23.
2000: Tomokazu Yoshizaki; S Teranishi; Osamu Matsui; Mitsuru Furukawa
Internal carotid artery aneurysm presenting as a large pharyngeal mass.
The Annals of otology, rhinology, and laryngology 2000;109(7):690-2.
2000: Shigeyuki Murono; Tomokazu Yoshizaki; Hiroshi Sato; H Takeshita; Manabu Furukawa; Joseph S Pagano
Aspirin inhibits tumor cell invasiveness induced by Epstein-Barr virus latent membrane protein 1 through suppression of matrix metalloproteinase-9 expression.
Cancer research 2000;60(9):2555-61.
2000: K R Kim; Tomokazu Yoshizaki; Hisashi Miyamori; K Hasegawa; Toshiyuki Horikawa; Mitsuru Furukawa; S Harada; Motoharu Seiki; Hiroshi Sato
Transformation of Madin-Darby canine kidney (MDCK) epithelial cells by Epstein-Barr virus latent membrane protein 1 (LMP1) induces expression of Ets1 and invasive growth.
Oncogene 2000;19(14):1764-71.
1999: Tomokazu Yoshizaki; Hiroshi Sato; Shigeyuki Murono; Joseph S Pagano; Mitsuru Furukawa
Matrix metalloproteinase 9 is induced by the Epstein-Barr virus BZLF1 transactivator.
Clinical & experimental metastasis 1999;17(5):431-6.
1999: H Takeshita; Tomokazu Yoshizaki; William E Miller; Hiroshi Sato; Manabu Furukawa; Joseph S Pagano; Nancy Raab-Traub
Matrix metalloproteinase 9 expression is induced by Epstein-Barr virus latent membrane protein 1 C-terminal activation regions 1 and 2.
Journal of virology 1999;73(7):5548-55.
1999: Naohiro Wakisaka; Q H Wen; Tomokazu Yoshizaki; T Nishimura; Mitsuru Furukawa; Ei Kawahara; I Nakanishi
Association of vascular endothelial growth factor expression with angiogenesis and lymph node metastasis in nasopharyngeal carcinoma.
The Laryngoscope 1999;109(5):810-4.
1999: Shigeyuki Murono; Tomokazu Yoshizaki; C S Park; Mitsuru Furukawa
Association of Epstein-Barr virus infection with p53 protein accumulation but not bcl-2 protein in nasopharyngeal carcinoma.
Histopathology 1999;34(5):432-8.
1999: Tomokazu Yoshizaki; T Horikawa; Akitaka Nonomura; Mitsuru Furukawa
Leiomyosarcoma of the larynx.
The Journal of laryngology and otology 1999;113(2):167-9.
1998: S C Key; Tomokazu Yoshizaki; Joseph S Pagano
The Epstein-Barr virus (EBV) SM protein enhances pre-mRNA processing of the EBV DNA polymerase transcript.
Journal of virology 1998;72(11):8485-92.
1998: Tomokazu Yoshizaki; Hiroshi Sato; Mitsuru Furukawa; Joseph S Pagano
The expression of matrix metalloproteinase 9 is enhanced by Epstein-Barr virus latent membrane protein 1.
Proceedings of the National Academy of Sciences of the United States of America 1998;95(7):3621-6.
1997: Shigeyuki Murono; Tomokazu Yoshizaki; S Tanaka; H Takeshita; C S Park; Mitsuru Furukawa
Detection of Epstein-Barr virus in nasopharyngeal carcinoma by in situ hybridization and polymerase chain reaction.
The Laryngoscope 1997;107(4):523-6.
1997: Mitsuru Furukawa; Shigeyuki Murono; S Nakagawa; H Takeshita; Tomokazu Yoshizaki
[Detection of Epstein-Barr virus genomes in nasopharyngeal carcinoma].
Nihon rinsho. Japanese journal of clinical medicine 1997;55(2):346-9.
1997: Tomokazu Yoshizaki; Hiroshi Sato; Y Maruyama; Shigeyuki Murono; M Furukawa; C S Park; Motoharu Seiki
Increased expression of membrane type 1-matrix metalloproteinase in head and neck carcinoma.
Cancer 1997;79(1):139-44.
1996: Mitsuru Furukawa; I Nagayama; Shigeyuki Murono; H Takeshita; T Nishimura; Tomokazu Yoshizaki
[Interaction between Epstein-Barr virus (EBV) gene expression and antibodies to EBV in nasopharyngeal carcinomas].
Rinsho byori. The Japanese journal of clinical pathology 1996;44(9):832-7.
1996: Q H Wen; T Miwa; Tomokazu Yoshizaki; I Nagayama; Mitsuru Furukawa; H Nishijima
Prognostic value of EGFR and TGF-alpha in early laryngeal cancer treated with radiotherapy.
The Laryngoscope 1996;106(7):884-8.
1994: Tomokazu Yoshizaki; T Takimoto; H Takeshita; Shigenori Tanaka; Mitsuru Furukawa; Motoharu Seiki; H Sato
Epstein-Barr virus lytic cycle spreads via cell fusion in a nasopharyngeal carcinoma hybrid cell line.
The Laryngoscope 1994;104(1 Pt 1):91-4.